Personal information

No personal information available

Activities

Collapse all

Works (13)

MSCs Suppress Macrophage Necroptosis and Foster Liver Regeneration by Modulating SP1/SK1 Axis in Treating Acute Severe Autoimmune Hepatitis

Advanced Science
2025-02-03 | Journal article
DOI: 10.1002/advs.202408974
Contributors: Ran An; Zhengyi Zhu; Yuyan Chen; Wenxian Guan; Jinglin Wang; Haozhen Ren
Source: check_circle
Crossref

Bioresponsive hydrogel microfibers for neuroblastoma drug evaluation

2025-01-03 | Preprint
DOI: 10.22541/au.173586979.94257316/v1
Contributors: Taiyu Song; Qiyang Shen; Yi Cheng; Yue Zhi; Guangling Liu; Haozhen Ren; Jinglin Wang
Source: check_circle
Crossref

Microfluidic 3D printing hydrogels based on fish liver decellularized extracellular matrix for liver regeneration

Smart Medicine
2024-12 | Journal article
DOI: 10.1002/SMMD.20240056
Contributors: Haozhen Ren; Danqing Huang; Mengdi Qiu; Lingling Xue; Shaoshi Zhu; Jingjing Gan; Cheng Chen; Dayu Chen; Jinglin Wang
Source: check_circle
Crossref

MVP enhances FGF21‐induced ferroptosis in hepatocellular carcinoma by increasing lipid peroxidation through regulation of NOX4

Clinical and Translational Science
2024-08 | Journal article
DOI: 10.1111/cts.13910
Contributors: Jinkun Xia; Boqi Fu; Zhe Wang; Gaolin Wen; Quanshui Gu; Dayu Chen; Haozhen Ren
Source: check_circle
Crossref

CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma

Cell Death Discovery
2024-01-19 | Journal article
DOI: 10.1038/s41420-023-01777-4
Contributors: Yuyan Chen; Zhengyi Zhu; Xingyu Wu; Hui Li; Wenxian Guan; Haozhen Ren
Source: check_circle
Crossref

Emerging optogenetics technologies in biomedical applications

Smart Medicine
2023-11 | Journal article
DOI: 10.1002/SMMD.20230026
Contributors: Haozhen Ren; Yi Cheng; Gaolin Wen; Jinglin Wang; Min Zhou
Source: check_circle
Crossref

Roles of N6‐methyladenosine epitranscriptome in non‐alcoholic fatty liver disease and hepatocellular carcinoma

Smart Medicine
2023-08 | Journal article
DOI: 10.1002/SMMD.20230008
Contributors: Yuyan Chen; Zhengyi Zhu; Lu Zhang; Jinglin Wang; Haozhen Ren
Source: check_circle
Crossref

FOXO1 regulates Th17 cell-mediated hepatocellular carcinoma recurrence after hepatic ischemia-reperfusion injury

Cell Death & Disease
2023-06-17 | Journal article
DOI: 10.1038/s41419-023-05879-w
Contributors: Haozhen Ren; Yuyan Chen; Zhengyi Zhu; Jinkun Xia; Shujun Liu; Yingzhe Hu; Xueqian Qin; Lu Zhang; Yitao Ding; Senzhe Xia et al.
Source: check_circle
Crossref

Multidimensional landscape of non‐alcoholic fatty liver disease‐related disease spectrum uncovered by big omics data: Profiling evidence and new perspectives

Smart Medicine
2023-05 | Journal article
DOI: 10.1002/SMMD.20220029
Contributors: Zhengyi Zhu; Yuyan Chen; Xueqian Qin; Shujun Liu; Jinglin Wang; Haozhen Ren
Source: check_circle
Crossref

Celery‐derived scaffolds with liver lobule‐mimicking structures for tissue engineering transplantation

Smart Medicine
2022-12 | Journal article
DOI: 10.1002/SMMD.20220002
Contributors: Jinglin Wang; Xueqian Qin; Bin Kong; Haozhen Ren
Source: check_circle
Crossref

Antibiotic pretreatment attenuates liver ischemia–reperfusion injury by Farnesoid X receptor activation

Cell Death & Disease
2022-05-21 | Journal article
DOI: 10.1038/s41419-022-04955-x
Contributors: Hanyi Liu; Jinglin Wang; Yitao Ding; Xiaolei Shi; Haozhen Ren
Source: check_circle
Crossref

TNFα-Mediated Necroptosis Aggravates Ischemia-Reperfusion Injury in the Fatty Liver by Regulating the Inflammatory Response

Oxidative Medicine and Cellular Longevity
2019-05-12 | Journal article
DOI: 10.1155/2019/2301903
Contributors: Faji Yang; Longcheng Shang; Shuai Wang; Yang Liu; Haozhen Ren; Wei Zhu; Xiaolei Shi
Source: check_circle
Crossref

Lipometabolism and Glycometabolism in Liver Diseases

BioMed Research International
2018-12-12 | Journal article
DOI: 10.1155/2018/1287127
Contributors: Hao-ran Ding; Jing-lin Wang; Hao-zhen Ren; Xiao-lei Shi
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for Advanced functional materials. (1)
How many people are using ORCID?